StockData
Exelixis, Inc. logo

Exelixis, Inc. (EXEL) stock

EXELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends January 1
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 29, 2026Score 18/301% above fair value
$69.00−0.84 (-1.20%)

Close on Nov 13, 2026Market cap $16.84BP/E 20.7Yield –

Exelixis statistics

99 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Jan 11, 2027 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Oct 2, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$16.84B
$275.32M
Enterprise Value
$15.94B
$144.91M
PE Ratio
20.66
25.11
PS Ratio
6.74
3.66
PB Ratio
9.18
2.01
P/TBV Ratio
9.51
2.22
P/FCF Ratio
14.50
17.86
P/OCF Ratio
14.35
12.99

Enterprise valuationIndustry

EV / Sales
6.39
2.57
EV / EBITDA
15.46
16.50
EV / EBIT
15.89
19.31
EV / FCF
13.73
22.27

Share statisticsIndustry

Shares Change (YoY)
-7.47%
10.8%
Shares Change (QoQ)
-1.69%
0.49%
Float
222M
49M
Shares Held by Insiders
9.05%
11.6%
Shares Held by Institutions
106.5%
56.4%

Short sellingIndustry

Short Interest
26M
–
Short Interest Change
-6.30%
-0.80%
Short % of Float
11.5%
8.98%
Short % of Shares Outstanding
10.5%
6.30%
Days to Cover
11.71
5.16

Stock price statisticsIndustry

52-Week High
$73.69
–
52-Week Low
$39.71
–
20-Day Moving Average
$67.96
–
50-Day Moving Average
$62.29
–
200-Day Moving Average
$52.24
–
Average True Range (14)
$2.12
–
Price Change (1 Week)
-0.82%
-1.15%
Price Change (1 Month)
9.82%
-4.86%
Price Change (3 Months)
31.9%
-21.1%
Price Change (6 Months)
37.6%
-20.7%
Price Change (YTD)
57.4%
-23.6%
Price Change (1 Year)
58.3%
-22.7%
Price Change (3 Years)
222.9%
-29.5%
Price Change (5 Years)
281.2%
-77.8%
Price Change (10 Years)
311.7%
-65.4%
Average Volume (10 Days)
3M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
2M
–
Relative Volume
0.61
0.70
Relative Strength Index (14)
58.6
43.4
Volatility (1 Year)
34.0%
80.1%
Beta (5 Years)
0.72
1.07

MarginsIndustry

Gross Margin
96.3%
53.1%
Operating Margin
40.2%
-38.7%
Profit Margin
35.5%
-31.6%
EBITDA Margin
41.3%
-27.7%
FCF Margin
46.5%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
44.3%
-50.3%
Return on Assets (ROA)
33.2%
-40.6%
Return on Invested Capital (ROIC)
75.0%
-33.1%
Return on Capital Employed (ROCE)
47.7%
-38.0%

Financial positionIndustry

Current Ratio
3.21
3.30
Quick Ratio
2.96
2.39

GrowthIndustry

Revenue Growth (YoY)
9.12%
6.82%
Net Income Growth (YoY)
30.6%
-14.4%
EPS Growth (YoY)
40.9%
-12.3%
FCF Growth (YoY)
48.9%
6.85%
Revenue Growth (3Y CAGR)
12.9%
2.25%
Revenue Growth (5Y CAGR)
18.6%
6.41%
EPS Growth (3Y CAGR)
70.6%
1.30%
EPS Growth (5Y CAGR)
51.4%
3.78%

EfficiencyIndustry

Asset Turnover
0.94
0.40
Inventory Turnover
3.26
2.73
Revenue Per Employee
$2.32M
$429.29K
Profits Per Employee
$821.86K
-$690.06K
Employee Count
1,077
75
WACC
8.68%
10.2%

Income statement (TTM)Industry

Revenue
$2.50B
$66.37M
Gross Profit
$2.40B
$120.78M
Operating Income
$1.00B
-$21.40M
Net Income
$885.14M
-$22.39M
EBITDA
$1.03B
-$17.04M
EPS (Diluted)
$3.34
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$892.02M
$17.80M
Net Cash Per Share
$3.66
$0.80
Equity (Book Value)
$1.83B
$53.27M
Book Value Per Share
$7.52
$1.50
Tangible Book Value
$1.77B
$26.82M
Working Capital
$909.75M
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
$1.17B
-$12.35M
Capital Expenditures
-$11.97M
-$1.00M
Free Cash Flow
$1.16B
-$18.21M
FCF Per Share
$4.76
-$0.42

Dividends and yieldsIndustry

Earnings Yield
5.26%
-22.0%
FCF Yield
6.90%
-9.44%
Buyback Yield
7.49%
-0.76%
Shareholder Yield
7.49%
0.00%

Taxes and interestIndustry

Income Tax
$180.70M
$73.00K

Scores and fair valueIndustry

Graham Number
$23.77
$19.34
Graham Upside
-65.6%
-46.6%
Altman Z-Score
17.46
0.23
Piotroski F-Score
7
4
Beneish M-Score
-2.61
-2.63
Lynch Fair Value
$83.50
–
Lynch Upside
21.0%
-28.9%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodEXELS&P 500DifferenceEXEL per yearS&P 500 per year
1 month+15.9%-3.0%+19.0 pts
3 months+36.3%-2.8%+39.1 pts
Year to date+57.4%+11.5%+45.9 pts
1 year+62.9%+13.5%+49.5 pts
3 years+229.5%+77.7%+151.8 pts+48.8%+21.1%
5 years+281.2%+72.6%+208.6 pts+30.7%+11.5%
10 years+320.7%+308.2%+12.6 pts+15.5%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

26M EXEL shares were sold short on Oct 30, 2026, down 6.3% from the previous report, or 11.53% of the shares available to trade. At recent volumes it would take 11.7 days to buy them back. Over the last 20 sessions, 52.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202625,593,708-6.3%2,185,68311.7
Oct 15, 202627,313,139-3.1%2,410,17911.3
Sep 30, 202628,183,726+6.8%2,228,19612.7
Sep 15, 202626,400,456-7.9%2,131,65512.4
Aug 31, 202628,656,285+2.2%1,925,98614.9
Aug 14, 202628,031,459-2.5%3,217,4838.7
Jul 31, 202628,749,664-7.0%2,142,04613.4
Jul 15, 202630,913,414+8.3%2,439,20612.7
Jun 30, 202628,539,118-6.8%3,327,7618.6
Jun 15, 202630,635,016+3.1%2,261,90413.5
May 29, 202629,707,071-1.9%2,404,61812.3
May 15, 202630,278,606+0.9%3,303,5519.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?